OTC and citrullinemia type I: Plasma metabolites instead highlighted argininemia, citrullinemia, and ornithine transcarbamylase deficiency (q = 0.0644), though the urea cycle and associated pathways metabolite set was not significant (q = 0.197; Figure 5D).